Learn about Catalyst Pharmaceuticals, its CEO Patrick J. McEnany, and their participation in the Piper Sandler Healthcare Conference. Discover Catalyst's innovative research in rare diseases.
X4 Pharmaceuticals appoints R. Keith Woods as independent director, bringing extensive life sciences expertise to their Board. Exciting times ahead for rare immunodeficiencies treatment!